CBD Use and Liver Injury: Practical Considerations for Primary Care - Frankly Speaking Ep 339
2023-07-31
Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-339
Overview: In this episode, we dive into a recent systematic review and meta-analysis confirming the association between cannabidiol (CBD) use and hepatotoxicity. Gain a deeper understanding of clinical applications and the delicate balance of risks and benefits when discussing CBD use with your patients.
Episode resource links:
- Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023 Mar 13. doi: 10.1111/joim.13627. Epub ahead of print. PMID: 36912195.
- https://store.samhsa.gov/sites/default/files/pep22-06-04-003.pdf
Guest: Jillian Joseph, MPAS, PA-C
Music Credit: Richard Onorato
More Episodes
Is it Time to Stop Checking LDL-C? - Frankly Speaking Ep 201
2020-12-07
675
2020-12-07
675
Favorite Podcast of the Last 200! - Frankly Speaking Ep 200
2020-11-30
614
2020-11-30
614
That Cup of Joe – Good for You! - Frankly Speaking Ep 196
2020-11-02
544
2020-11-02
544
Get this podcast on your
phone, FREE
